LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $981,000 | +84.1% | 7,161 | +36.5% | 0.01% | +100.0% |
| Q4 2016 | $533,000 | -0.4% | 5,246 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $535,000 | -32.8% | 5,246 | -19.5% | 0.01% | -28.6% |
| Q2 2016 | $796,000 | -16.6% | 6,519 | -26.8% | 0.01% | -12.5% |
| Q1 2016 | $954,000 | -18.7% | 8,906 | -17.8% | 0.01% | -20.0% |
| Q4 2015 | $1,174,000 | +25.3% | 10,829 | -1.0% | 0.01% | +25.0% |
| Q3 2015 | $937,000 | -65.8% | 10,942 | -59.7% | 0.01% | -60.0% |
| Q2 2015 | $2,743,000 | +29.1% | 27,185 | -1.4% | 0.02% | +25.0% |
| Q1 2015 | $2,125,000 | +14.1% | 27,564 | -21.2% | 0.02% | +14.3% |
| Q4 2014 | $1,862,000 | +108.7% | 34,988 | +84.3% | 0.01% | +100.0% |
| Q3 2014 | $892,000 | -30.6% | 18,989 | -7.9% | 0.01% | -22.2% |
| Q2 2014 | $1,285,000 | – | 20,624 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |